Millrace Asset Group’s AtriCure ATRC Stock Holding History

Millrace Asset Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.01M	Buy	71,708 +1,660	+2%	+$40.9K	2.04%	15
2024 Q2	$1.59M	Buy	70,048 +15,699	+29%	+$362K	1.55%	27
2024 Q1	$1.65M	Buy	+54,349	New	+$1.82M	1.66%	24
2023 Q4	–	Sell	-48,730	Closed	-$2.13M	–	69
2023 Q3	$2.13M	Sell	48,730 -6,629	-12%	-$323K	2.64%	8
2023 Q2	$2.73M	Buy	+55,359	New	+$2.55M	2.86%	7
2022 Q4	–	Sell	-37,051	Closed	-$1.45M	–	50
2022 Q3	$1.45M	Sell	37,051 -16,088	-30%	-$736K	1.83%	21
2022 Q2	$2.17M	Buy	+53,139	New	+$2.52M	2.03%	19
2020 Q2	–	Sell	-28,814	Closed	-$968K	–	76
2020 Q1	$968K	Buy	+28,814	New	+$1.04M	1.46%	40
2016 Q1	–	Sell	-61,480	Closed	-$1.38M	–	52
2015 Q4	$1.38M	Buy	61,480 +7,300	+13%	+$150K	1.44%	39
2015 Q3	$1.19M	Sell	54,180 -47,358	-47%	-$1.18M	1.28%	39
2015 Q2	$2.5M	Buy	101,538 +3,998	+4%	+$89.3K	2.61%	8
2015 Q1	$2M	Buy	+97,540	New	+$1.89M	2.21%	19

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Millrace Asset Group's ATRC Position: Q3 2024 in Review

Millrace Asset Group increased its AtriCure (ATRC) stake by 2.4% in Q3 2024, buying an estimated $40.9K and bringing the position to 71,708 shares worth $2.01M. The position accounts for 2.04% of the portfolio, ranked #15.

Millrace Asset Group first reported a position in ATRC in Q1 2015 and has held it in 12 quarters since. The position peaked at $2.73M in Q2 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

Millrace Asset Group held 71,708 shares of AtriCure worth $2.01M as of Q3 2024.
Millrace Asset Group bought 1,660 AtriCure shares in Q3 2024, an estimated $40.9K.
AtriCure made up 2.04% of Millrace Asset Group's portfolio in Q3 2024, its #15 holding.
Millrace Asset Group first reported a position in AtriCure in Q1 2015 and has held it in 12 quarters since.
Millrace Asset Group's AtriCure position peaked at $2.73M in Q2 2023.
201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.